A phase 2 clinical trial published last month showed that the experimental drug elraglusib, when combined with standard chemotherapy, doubled one-year survival rates for patients with metastatic pancreatic cancer—a disease …
Headlinez News is an independent digital newsroom delivering accurate, timely, and trustworthy reporting across the U.S. and worldwide. Our mission is to keep readers informed with verified facts, expert analysis, and credible journalism that puts truth first.
@2025 – Hosted by ByoHosting – Most Recommendeed Webhhosting. For complains, abuse, advertising contact: office@byohosting.com
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More
